These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 22273986)

  • 21. NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States.
    Marrero JA; Fontana RJ; Su GL; Conjeevaram HS; Emick DM; Lok AS
    Hepatology; 2002 Dec; 36(6):1349-54. PubMed ID: 12447858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiological trends of hepatocellular carcinoma in Austria.
    Pinter M; Hucke F; Zielonke N; Trauner M; Sieghart W; Peck-Radosavljevic M
    Dig Dis; 2014; 32(6):664-9. PubMed ID: 25376282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatocellular carcinoma and hepatitis C in Mexico.
    Mondragón-Sánchez R; Garduño-López AL; Hernández-Castillo E; Gómez-Gómez E; Ruiz-Molina JM
    Hepatogastroenterology; 2005; 52(64):1159-62. PubMed ID: 16001652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hepatocellular carcinoma: the significance of cirrhosis for treatment and prognosis--retrospective study].
    Witjes CD; de Man RA; Eskens FA; Dwarkasing RS; Zondervan PE; Verhoef C; Ijzermans JN
    Ned Tijdschr Geneeskd; 2010; 154():A1747. PubMed ID: 20719013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States.
    El-Serag HB; Mason AC; Key C
    Hepatology; 2001 Jan; 33(1):62-5. PubMed ID: 11124821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Double cancer, cholangiocellular and hepatocellular carcinomas, in the cirrhotic liver.
    Yoshikawa T; Hirota S; Matsumoto S; Izaki K; Fukuda T; Sugimura K; Maeda S; Kitagaki H
    Radiat Med; 2002; 20(1):33-6. PubMed ID: 12002601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
    Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
    Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Registries in Japan: current status of hepatocellular carcinoma in Japan. Liver Cancer Study Group of Japan.
    Arii S; Okamoto E; Imamura M
    Semin Surg Oncol; 1996; 12(3):204-11. PubMed ID: 8727612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatic resection for combined hepatocellular and cholangiocarcinoma.
    Liu CL; Fan ST; Lo CM; Ng IO; Lam CM; Poon RT; Wong J
    Arch Surg; 2003 Jan; 138(1):86-90. PubMed ID: 12511158
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined hepatocellular and cholangiocarcinoma: demographic, clinical, and prognostic factors.
    Jarnagin WR; Weber S; Tickoo SK; Koea JB; Obiekwe S; Fong Y; DeMatteo RP; Blumgart LH; Klimstra D
    Cancer; 2002 Apr; 94(7):2040-6. PubMed ID: 11932907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatocellular carcinoma incidence in Florida. Ethnic and racial distribution.
    Shea KA; Fleming LE; Wilkinson JD; Wohler-Torres B; McKinnon JA
    Cancer; 2001 Mar; 91(5):1046-51. PubMed ID: 11251958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatocellular carcinoma - United States, 2001-2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 May; 59(17):517-20. PubMed ID: 20448528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Descriptive study of hepatocellular carcinoma in noncirrhotic liver].
    Núñez Martínez Ó; Matilla Peña A; Merino Rodríguez B; Díaz Sánchez A; Colón Rodríguez A; Ramón Botella E; Yepes Barreto I; Prieto Martín M; Tellado Rodríguez JM; Clemente Ricote G
    Gastroenterol Hepatol; 2011 May; 34(5):322-8. PubMed ID: 21530005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trends in incidence of hepatocellular carcinoma after diagnosis of hepatitis B or C infection: a population-based cohort study, 1992-2007.
    Thein HH; Walter SR; Gidding HF; Amin J; Law MG; George J; Dore GJ
    J Viral Hepat; 2011 Jul; 18(7):e232-41. PubMed ID: 21692938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The natural history of chronic hepatitis B: a retrospective study.
    Wu GC; Zhou WP; Zhao YR; Guo SH; Wang ZY; Zou SB; Zhang QH; Ren H; Huang AL; Zhang DF
    Hepatobiliary Pancreat Dis Int; 2003 Nov; 2(4):566-70. PubMed ID: 14627521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relative etiological role of prior hepatitis B virus infection and nonalcoholic fatty liver disease in the development of non-B non-C hepatocellular carcinoma in a hepatitis B-endemic area.
    Cho EJ; Kwack MS; Jang ES; You SJ; Lee JH; Kim YJ; Yoon JH; Lee HS
    Digestion; 2011; 84 Suppl 1():17-22. PubMed ID: 22156481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma: a Western experience.
    Portolani N; Baiocchi GL; Coniglio A; Piardi T; Grazioli L; Benetti A; Ferrari Bravo A; Giulini SM
    Ann Surg Oncol; 2008 Jul; 15(7):1880-90. PubMed ID: 18443881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary liver cancer in Sri Lanka.
    Nagaratnam N; Ramachandra V; Jiffry AJ; Bhuvanendran N
    J Trop Med Hyg; 1984 Aug; 87(4):185-7. PubMed ID: 6097698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatocellular carcinoma in renal transplant recipients.
    Chuang CH; Chien YS; Cheng YT; Chen YT; Hu TH; Hsieh H
    Transplant Proc; 2008 Sep; 40(7):2392-4. PubMed ID: 18790244
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term trends of the incidence of hepatocellular carcinoma in the Nagasaki prefecture, Japan.
    Taura N; Yatsuhashi H; Nakao K; Ichikawa T; Ishibashi H
    Oncol Rep; 2009 Jan; 21(1):223-7. PubMed ID: 19082466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.